2016 IMAP Netherlands Global M&A Report for Pharma/Biotech online report

2015 was an exceptional year for the Pharma and Biotech industry. We are pleased to announce that the 2016 IMAP Netherlands Global M&A Report for Pharma/Biotech online report is available now. This new report offers insights into what moved the industry, looking in detail at merger mania, price pressure in the US and accelerating innovation. It also outlines what are expected to be key drivers for M&A activity in 2016, explaining the emerging 4 Strategic Archetypes as well as examining portfolio deals and genomics.

The full report is available here: IMAP Netherlands_2016_Global_MA_Report__Pharma__2CF5D858BC6E3